Expanding on previous discussions of lipid metabolic reprogramming, this section delves into the roles of SREBP, Liver X receptors (LXR), PPAR, and MGLL in tumor-associated lipid metabolism, examines oncogene-driven lipid metabolic regulation across various cancers, and explores lipid metabolic reprogramming in other components of the TME. Here, MGLL is linked to neoplasm.